0000000000801361

AUTHOR

R Valenza

showing 3 related works from this author

Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer.

1992

erythropoietin anemia advanced cancer
researchProduct

Short term intensive preoperative chemotherapy with high doses of epirubicin plus G-CSF rescue for locally advanced Stage III breast carcinoma.

1996

Settore MED/18 - Chirurgia GeneraleSettore MED/06 - Oncologia MedicaBreast carcinoma preoperative chemotherapy G.CSF
researchProduct

Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma

1994

Thirty consecutive patients with stage IIIB-IV non small cell lung cancer were treated with a combination of cisplatin 80 mg/m2 on day 1 plus vinorelbine 25-30 mg/m2 on days 1, 8. This cycle was repeated every 3 weeks. The overall response rate was 46%, with 1 patient showing a complete response and 13 patients (43%) a partial response with a mean duration of 8.4+ months. Six patients had a stabilization and 10 progressed. The main toxicities were represented by myelosuppression and nausea/vomiting. Grade 3 leukopenia was seen in 33% of cases, grade 2 thrombocytopenia in 12%, and phlebitis in the injection vein in 16%. Mild constipation was also recorded. The combination of cisplatin plus v…

MaleLung NeoplasmsSettore MED/06 - Oncologia MedicaVinorelbineMiddle AgedVinblastineLung carcinoma ChemotherapySettore MED/18 - Chirurgia GeneraleCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleCisplatinAgedNeoplasm Staging
researchProduct